High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer

BACKGROUND: Programmed death ligand 1 (PD‐L1) inhibitor has been approved as one of the standard therapies for various cancers. Some reports have shown that serum PD‐L1 level is associated with advanced tumor stages and poor prognosis; however, corresponding pathological information in esophageal ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Masaaki, Yajima, Satoshi, Suzuki, Takashi, Oshima, Yoko, Nanami, Tatsuki, Sumazaki, Makoto, Shiratori, Fumiaki, Funahashi, Kimihiko, Tochigi, Naobumi, Shimada, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013049/
https://www.ncbi.nlm.nih.gov/pubmed/31865635
http://dx.doi.org/10.1002/cam4.2789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013049/
https://www.ncbi.nlm.nih.gov/pubmed/31865635
http://dx.doi.org/10.1002/cam4.2789

Ejemplares similares